Drug copayment coupons to reduce patient cost-sharing have become nearly ubiquitous for high-priced brand … equilibrium price effects of coupons, we employ individual-level data to estimate a discrete choice model of demand for multiple … sclerosis drugs. We use our demand estimates to parameterize a model of drug price negotiations. For this category of drugs, we …

Virtual cross-border medical tourism allows many residents in the United States to purchase brand name medicines from … companies in Mexico without travelling there. Monthly economic reports indicate that the online brand name pharmaceutical … study indicate that online medicine prices in Mexico respond very rapidly to online prices changes in the high-price market. …

. The Tariff Commission Report of 1968, a turning point in the price control policies of the 1960s, is examined. The …

, given relatively high demand elasticities for pharmaceuticals in these populations; modest cash resources for health care …

This paper reports the results from a statistical analysis of pharmaceutical price negotiations in Germany, where the … pricing system was changed in 2011 in order to tie prices more to the benefits of the pharmaceuticals. A multiple linear … regression of 187 pharmaceuticals which were assessed from 2011 to 2017 suggests that, despite the change, the manufacturers …

This paper reports the results from a statistical analysis of pharmaceutical price negotiations in Germany, where the … pricing system was changed in 2011 in order to tie prices more to the benefits of the pharmaceuticals. A multiple linear … regression of 187 pharmaceuticals which were assessed from 2011 to 2017 suggests that, despite the change, the manufacturers …

We analyze how a manufacturer with a brand-name drug close to patent expiration decides to launch a product … innovation, the incumbent firm competes for the price-sensitive physicians. However, for low levels of innovation, the incumbent … firm prefers to exploit the loyal physicians and to charge the monopoly price. The equilibrium level of innovation exhibits …